Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Treace Medical Concepts (TMCI) Shares Issued (2020 - 2025)

Treace Medical Concepts' Shares Issued history spans 6 years, with the latest figure at -$476000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 935.09% year-over-year to -$476000.0; the TTM value through Sep 2025 reached $533000.0, down 2.91%, while the annual FY2024 figure was $428000.0, 77.1% down from the prior year.
  • Shares Issued reached -$476000.0 in Q4 2025 per TMCI's latest filing, down from $241000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $107.5 million in Q1 2023 to a low of -$105.8 million in Q3 2023.
  • Average Shares Issued over 5 years is $394625.0, with a median of $148500.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: crashed 32849.23% in 2021, then skyrocketed 2912.5% in 2025.
  • A 5-year view of Shares Issued shows it stood at -$105.8 million in 2021, then skyrocketed by 102.07% to $2.2 million in 2022, then tumbled by 91.86% to $178000.0 in 2023, then plummeted by 67.98% to $57000.0 in 2024, then crashed by 935.09% to -$476000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Shares Issued are -$476000.0 (Q4 2025), $241000.0 (Q3 2025), and $116000.0 (Q2 2025).